| Financial Year |
March 31 2023 |
| Monetary Funds |
1,144,784,438.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
55,888,359.69 |
| Accounts Receivable |
990,864,590.52 |
| Advances to Suppliers |
43,308,922.29 |
| Other Receivables |
28,920,640.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
431,490,077.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
51,054,797.93 |
| Total Current Assets |
2,980,112,059.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,124,108,275.36 |
| Investment Properties |
18,787,612.52 |
| Fixed Assetes |
1,223,877,120.04 |
| Under-construction Projects |
753,255,270.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
286,500,655.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,946,472.16 |
| Deferred Income Tax Assets |
38,411,768.12 |
| Other Non-Current Assets |
607,500,213.95 |
| Sub-Total of Non-Current Assets |
4,059,086,399.45 |
| Total Assets |
7,039,198,458.76 |
| Short-Term Loans |
550,309,054.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
815,842.79 |
| Accounts Payable |
337,101,134.65 |
| Accounts Received In Advance |
2,642,857.08 |
| Employee Compensation Payable |
26,752,789.55 |
| Taxes Payable |
41,517,780.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,233,752.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,253,701.68 |
| Other Current Liabilities |
2,662,335.42 |
| Sub-Total of Current Liabilities |
1,008,833,987.07 |
| Long-term Loans |
552,640,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
69,180,996.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
790,748,547.19 |
| Total Liabilities |
1,799,582,534.26 |
| Paid-In Capital(Or Share Stock) |
1,672,697,766.00 |
| Capital Surplus |
1,140,662,756.16 |
| Surplus Reserve |
351,452,557.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,038,126,369.52 |
| Minority Stockholder's Interest |
42,899,509.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,196,716,415.45 |
| Owner's Equity（Stockholder's Equity） |
5,239,615,924.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,039,198,458.76 |
